Malpractice trends involving active surveillance across cancers

HMN 2024 – Active surveillance is an established practice for managing certain low-risk cancers that are unlikely to cause harm. It is an increasingly common and effective way to manage certain early-stage cancers, including those in the prostate, thyroid and kidney. However, adoption of active surveillance in practice has been hit-and-miss for several reasons. Among them, according to […]

 ……… Read More